Source:http://linkedlifedata.com/resource/pubmed/id/12134566
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2002-7-23
|
pubmed:abstractText |
Abnormal lipid and lipoprotein cholesterol values have been defined as a low-density lipoprotein (LDL) cholesterol (C) value of 160 mg/dL (4.1 mmol/L) or greater, a high-density lipoprotein (HDL) C value less than 40 mg/dL (1.0 mmol/L), triglycerides (TG) 150 mg/dL (1.7 mmol/L) or greater, and a lipoprotein (a) (Lp(a)) of 30 mg/dl or greater. Such values all increase coronary heart disease (CHD) risk. The National Cholesterol Education Program Adult Treatment Panel III guidelines continue to focus on optimizing LDL-C values (established as < 100 mg/dL or 2.6 mmol/L), especially in those with established CHD, diabetes, or a 10-year CHD risk over 20%. Dietary saturated fat (< 7% of calories) and cholesterol (< 200 mg/day) restriction, and the use of 3-hydroxy-3 methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors are the mainstays of treatment in this regard. Such treatment substantially reduces CHD risk. Severe hypertriglyceridemia (> 1000 mg/dL or 11.0 mmol/L) is associated with pancreatitis, and fat restriction, control of glucose, and fibrate therapy are indicated in such patients. Niacin is currently the most effective agent for lowering Lp(a) and raising HDL-C. Current recommendations for treatment by diet and drugs are outlined.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1096-6781
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
115-23
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12134566-Adult,
pubmed-meshheading:12134566-Age Factors,
pubmed-meshheading:12134566-Aged,
pubmed-meshheading:12134566-Cholesterol, HDL,
pubmed-meshheading:12134566-Cholesterol, LDL,
pubmed-meshheading:12134566-Coronary Disease,
pubmed-meshheading:12134566-Female,
pubmed-meshheading:12134566-Humans,
pubmed-meshheading:12134566-Hypercholesterolemia,
pubmed-meshheading:12134566-Hyperlipoproteinemias,
pubmed-meshheading:12134566-Hypertriglyceridemia,
pubmed-meshheading:12134566-Male,
pubmed-meshheading:12134566-Middle Aged,
pubmed-meshheading:12134566-Risk Factors
|
pubmed:articleTitle |
Diagnosis and management of lipoprotein abnormalities.
|
pubmed:affiliation |
Lipid and Heart Disease Prevention Clinic, Tufts-New England Medical Center, Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA.
|
pubmed:publicationType |
Journal Article,
Review
|